Stage age and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients

摘要

BackgroundPlasmablastic lymphoma (PBL) is a rare aggressive neoplasm with lymphoid and plasmacytic differentiation that is commonly associated with immunodeficiency and an unfavorable prognosis. Clinicopathologic features have been largely derived from cases reports and small series with limited outcome analyses.